Aethlon Medical Inc (AEMD) stock
AEMDNasdaqPharmaceutical PreparationsFiscal year ends March 31
$5.11+0.03 (+0.59%)
Close on Nov 18, 2026Market cap $3.63MP/E –Yield –
Aethlon Medical operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Aethlon Medical's operating income for the twelve months ending Mar 31, 2026 was -$7.29M. For fiscal 2026 it was -$7.29M. The highest annual figure on record is -$3.06M in fiscal 2014.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Mar 31, 2026 | -$7.29M | – |
| FY2025 | Mar 31, 2025 | -$9.34M | – |
| FY2024 | Mar 31, 2024 | -$12.64M | – |
| FY2023 | Mar 31, 2023 | -$11.90M | – |
| FY2022 | Mar 31, 2022 | -$10.42M | – |
| FY2021 | Mar 31, 2021 | -$7.89M | – |
| FY2020 | Mar 31, 2020 | -$5.93M | – |
| FY2019 | Mar 31, 2019 | -$6.00M | – |
| FY2018 | Mar 31, 2018 | -$4.83M | – |
| FY2017 | Mar 31, 2017 | -$6.10M | – |
| FY2016 | Mar 31, 2016 | -$4.38M | – |
| FY2015 | Mar 31, 2015 | -$3.99M | – |
| FY2014 | Mar 31, 2014 | -$3.06M | – |
| FY2013 | Mar 31, 2013 | -$3.58M | – |
| FY2012 | Mar 31, 2012 | -$3.11M | – |
| FY2011 | Mar 31, 2011 | -$4.56M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2027CQ2 2026 | Jun 30, 2026 | -$1.58M | – |
| Q4 FY2026CQ1 2026 | Mar 31, 2026 | -$1.93M | – |
| Q1 FY2026CQ2 2025 | Jun 30, 2025 | -$1.79M | – |
| Q4 FY2025CQ1 2025 | Mar 31, 2025 | -$2.00M | – |
| Q3 FY2025CQ4 2024 | Dec 31, 2024 | -$1.81M | – |
| Q2 FY2025CQ3 2024 | Sep 30, 2024 | -$2.90M | – |
| Q1 FY2025CQ2 2024 | Jun 30, 2024 | -$2.62M | – |
| Q4 FY2024CQ1 2024 | Mar 31, 2024 | -$2.49M | – |
| Q3 FY2024CQ4 2023 | Dec 31, 2023 | -$3.57M | – |
| Q2 FY2024CQ3 2023 | Sep 30, 2023 | -$3.18M | – |
| Q1 FY2024CQ2 2023 | Jun 30, 2023 | -$3.41M | – |
| Q4 FY2023CQ1 2023 | Mar 31, 2023 | -$2.48M | – |
| Q3 FY2023CQ4 2022 | Dec 31, 2022 | -$2.85M | – |
| Q2 FY2023CQ3 2022 | Sep 30, 2022 | -$3.67M | – |
| Q1 FY2023CQ2 2022 | Jun 30, 2022 | -$2.91M | – |
| Q4 FY2022CQ1 2022 | Mar 31, 2022 | -$3.79M | – |
| Q3 FY2022CQ4 2021 | Dec 31, 2021 | -$2.53M | – |
| Q2 FY2022CQ3 2021 | Sep 30, 2021 | -$2.01M | – |
| Q1 FY2022CQ2 2021 | Jun 30, 2021 | -$2.10M | – |
| Q4 FY2021CQ1 2021 | Mar 31, 2021 | -$2.26M | – |
| Q3 FY2021CQ4 2020 | Dec 31, 2020 | -$2.44M | – |
| Q2 FY2021CQ3 2020 | Sep 30, 2020 | -$1.77M | – |
| Q1 FY2021CQ2 2020 | Jun 30, 2020 | -$1.41M | – |
| Q4 FY2020CQ1 2020 | Mar 31, 2020 | -$1.79M | – |
| Q3 FY2020CQ4 2019 | Dec 31, 2019 | -$876.41K | – |
| Q2 FY2020CQ3 2019 | Sep 30, 2019 | -$1.70M | – |
| Q1 FY2020CQ2 2019 | Jun 30, 2019 | -$1.57M | – |
| Q4 FY2019CQ1 2019 | Mar 31, 2019 | -$1.59M | – |
| Q3 FY2019CQ4 2018 | Dec 31, 2018 | -$1.96M | – |
| Q2 FY2019CQ3 2018 | Sep 30, 2018 | -$1.35M | – |
| Q1 FY2019CQ2 2018 | Jun 30, 2018 | -$1.10M | – |
| Q4 FY2018CQ1 2018 | Mar 31, 2018 | -$1.27M | – |
| Q3 FY2018CQ4 2017 | Dec 31, 2017 | -$1.16M | – |
| Q2 FY2018CQ3 2017 | Sep 30, 2017 | -$1.24M | – |
| Q1 FY2018CQ2 2017 | Jun 30, 2017 | -$1.16M | – |
| Q4 FY2017CQ1 2017 | Mar 31, 2017 | -$1.50M | – |
| Q3 FY2017CQ4 2016 | Dec 31, 2016 | -$1.24M | – |
| Q2 FY2017CQ3 2016 | Sep 30, 2016 | -$2.23M | – |
| Q1 FY2017CQ2 2016 | Jun 30, 2016 | -$1.13M | – |
See a number that looks wrong?